NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-06-28 1250080bm96暂无昵称来自北京

投稿命中率:5.0
经验分享：6月17日投，6月23日rapid reject

181 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-04-18 ms3000002114550837 来自湖南省

偏重的研究方向：AD
经验分享：请问initial QC需要多久

210 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2021-12-27 小动量

什么样的题目能让审稿人眼前一亮？

977 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2021-12-28 Mia

文章题目有没有撰写模板？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-08-03 ms8000000670630039 来自黑龙江省

偏重的研究方向：AD
经验分享：好

154 0

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-05-24 ms2000000255319531 来自湖南省

偏重的研究方向：AD
经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿

194 0

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-04-18 ms7000001543288617 来自湖南省

偏重的研究方向：AD
经验分享：请问initial QC一般要多久呀

229 0

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2023-03-12 ms9000000042873657 来自广东省

我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。

243 0

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2022-02-11 ms2000001939126778

偏重的研究方向：神经系统疾病;Genetics
经验分享：多活动手脚

1166 0

[GetPortalCommentsPageByObjectIdResponse(id=2145224, encodeId=2fed2145224e9, content=投稿命中率:5.0 经验分享：6月17日投，6月23日rapid reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Wed Jun 28 15:56:05 CST 2023, time=2023-06-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126860, encodeId=41f621268606d, content=偏重的研究方向：AD 经验分享：请问initial QC需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d28639780, createdName=ms3000002114550837, createdTime=Tue Apr 18 21:48:06 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151067, encodeId=4669215106ec9, content=偏重的研究方向：AD 经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577a8298019, createdName=ms8000000670630039, createdTime=Thu Aug 03 12:17:17 CST 2023, time=2023-08-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2138870, encodeId=e52121388e07f, content=偏重的研究方向：AD 经验分享：我是2022年12月份投的稿，投出去即显示under review，一个半月后，审稿意见回来，一个意见中肯，一个意见负面，编辑拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54298406718, createdName=ms2000000255319531, createdTime=Wed May 24 20:19:21 CST 2023, time=2023-05-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126859, encodeId=2f2a2126859a4, content=偏重的研究方向：AD 经验分享：请问initial QC一般要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2a8232651, createdName=ms7000001543288617, createdTime=Tue Apr 18 21:32:14 CST 2023, time=2023-04-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2119030, encodeId=449721190305e, content=我想请问一下3月后neurology的新投稿系统为什么一直在卡，登录进去一直在说因为账号安全问题锁定登录时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ed8583157, createdName=ms9000000042873657, createdTime=Sun Mar 12 09:13:22 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=)]

2022-01-26 146070f9m77(暂无昵称)

12月22号投稿，1月26号被拒，中间没有任何状态变化。
拒稿信如下，一同拒绝了我转投他家其他杂志。
If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals.
投的生信方面的文章

855 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务